Natural Alternatives International (NAII) Operating Margin by Segment

Reveals profitability across different business segments, highlighting which areas are most efficient and where there might be room for improvement or strategic focus.

NAII’s profitability has split: patent and trademark licensing remains the stable, high‑margin engine, while private‑label contract manufacturing has shifted from historically modest profits to recurring losses, turning the manufacturing arm into a consistent drag and source of volatility. For investors this means the company’s earnings increasingly rely on a narrow, high‑margin licensing stream; restoring manufacturing margins via pricing, cost control, or portfolio changes is the key catalyst to de‑risk and sustain overall profitability.